Evidence map›Paper›PMID 41771780›Full record

ReviewMicrobiologyOpen2026

The Evaluation of Machine Learning Models Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) Spectra for the Prediction of Antibiotic Resistance in Klebsiella pneumoniae.

Stephen Mark Edward Fordham

Abstract readEvaluation StudyReview
In one paragraph

Review in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Stephen Mark Edward FordhamDepartment of Life & Environmental Sciences, Bournemouth University, Poole, UK.ORCID 0000-0002-7814-2880

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance in Klebsiella pneumoniae poses a major clinical challenge, driving development in rapid, diagnostic strategies that extend beyond conventional susceptibility testing. Twenty-three studies demonstrate that using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) spectra to create machine learning (ML) models yields rapid and accurate predictions of antibiotic resistance in K. pneumoniae. Across these studies, most models focused on carbapenem resistance and achieved Area Under the Receiver Operating Characteristic Curve (AUROC) values consistently above 0.90, with ensemble algorithms, particularly Random Forest, XGBoost, and Light Gradient Boosting Machine, and deep learning models such as Convolutional Neural Networks attaining accuracies as high as 97% and even AUROCs reaching 0.99 or higher. Sample sizes ranged from 35 to over 15,000 isolates, reinforcing the robustness of these findings across diverse clinical settings. In addition to high discrimination performance, this evaluation reports that ML models developed using MALDI-TOF-MS spectra shorten diagnostic turnaround from days (48-96 h with conventional methods) to minutes or hours, using existing MALDI-TOF-MS equipment for economical implementation. However, ML diagnostic tools remain constrained by limited external validation, spectra preprocessing protocols, and variability between different MALDI-TOF-MS platforms. These limitations may restrict model generalizability and clinical translation, highlighting the need for standardized workflows and larger multicenter evaluations.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialKlebsiella pneumoniaeMachine LearningSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBoosting Machine Learning AlgorithmsHumansKlebsiella InfectionsMicrobial Sensitivity TestsPrediction AlgorithmsPredictive Learning ModelsRandom ForestROC CurveAnti-Bacterial AgentsKlebsiella pneumoniaemachine learningMALDI–TOF–MSrapid diagnostics

Identifiers

PMID41771780
PMCPMC12953053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.